Ticker Hub
EBS — AI Analysis & Sentiment
5 recent AI-generated analyses for EBS. Sentiment and confidence insights updated continuously.
Emergent BioSolutions Reports First Quarter 2026 Financial Results
Emergent BioSolutions' Q1 2026 results exceeded internal guidance, and the company raised its full-year adjusted profitability outlook. This indica...
Apr 30, 2026Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142
Emergent BioSolutions secured a significant multi-year manufacturing contract, providing a new revenue stream and leveraging its expertise. This ca...
Apr 29, 2026Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
Emergent BioSolutions' new $34.5 million manufacturing and distribution contract represents a clear, fresh catalyst that could drive long-term reve...
Apr 28, 2026Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
Emergent BioSolutions has taken a significant step to improve its balance sheet by refinancing debt, which reduces future interest payments and ext...
Apr 16, 2026Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures
Emergent BioSolutions recently secured over $60 million in new smallpox medical countermeasures contracts. This substantial win strengthens its cor...
Mar 25, 2026